Eloxatin (oxaliplatin recalls
The FDA has published 2 recalls involving Eloxatin (oxaliplatin since 2012. The latest was reported on 11 Jul 2012. Most were for manufacturing (cgmp) deviations. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2012
Last 12 months0reported
Class I00% of total
Ongoing0latest 11 Jul 2012
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why eloxatin (oxaliplatin is recalled
Companies
By year
All eloxatin (oxaliplatin recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Eloxatin (OXALIplatin injection) 5 mg/mL injection, 100 mg recalled | sanofi-aventis US | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Eloxatin (OXALIplatin injection) 5 mg/mL Injection, 50 mg recalled | sanofi-aventis US | Manufacturing (CGMP) Deviations | Nationwide |
Should you stop taking Eloxatin (oxaliplatin?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.